Invention Grant
US07973166B2 N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B
有权
N-（2-氨基苯基）-4- [N-（吡啶-3-基） - 甲氧基羰基 - 氨基甲基] - 苯甲酰胺（MS-275）多晶型B
![N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B](/docs/US/2011-07-05/US07973166B2/abs.jpg.600x600.jpg)
- Patent Title: N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B
- Patent Title (中): N-（2-氨基苯基）-4- [N-（吡啶-3-基） - 甲氧基羰基 - 氨基甲基] - 苯甲酰胺（MS-275）多晶型B
-
Application No.: US12549458Application Date: 2009-08-28
-
Publication No.: US07973166B2Publication Date: 2011-07-05
- Inventor: Matthias Schneider , Michael Gottfried , Jens Geisler , Gabriele Winter
- Applicant: Matthias Schneider , Michael Gottfried , Jens Geisler , Gabriele Winter
- Applicant Address: DE Berlin
- Assignee: Bayer Schering Pharma AG
- Current Assignee: Bayer Schering Pharma AG
- Current Assignee Address: DE Berlin
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: EP08163274 20080829
- Main IPC: C07D213/56
- IPC: C07D213/56 ; A01N43/40
![N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B](/abs-image/US/2011/07/05/US07973166B2/abs.jpg.150x150.jpg)
Abstract:
The crystalline Polymorph B of N-(2-aminophenyl)-4-[N-(pyridine-3-yl)methoxy-carbonyaminomethyl]benzamide (MS-275) of formula I is described, as well as the process for the production of said compound, and its use as a medicament for the treatment of selected diseases.
Public/Granted literature
- US20100056585A1 N-(2-Aminophenyl)-4-[N-(Pyridine-3-yl)-Methoxycarbonyl-Aminomethyl]-Benzamide (MS-275) Polymorph B Public/Granted day:2010-03-04
Information query
